Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
VYGR — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

6.5

Margin Of Safety %

Put/Call OI Ratio

0.08

EPS Next Q Diff

-0.02

EPS Last/This Y

0.27

EPS This/Next Y

0.06

Price

3.97

Target Price

14.89

Analyst Recom

1.08

Performance Q

-2.94

Upside

-769.7%

Beta

1.4

Ticker: VYGR



20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09VYGR4.120.042.505831
2026-03-10VYGR4.990.050.145842
2026-03-11VYGR4.880.050.037024
2026-03-12VYGR4.860.050.067136
2026-03-13VYGR4.870.050.067136
2026-03-17VYGR3.930.060.067320
2026-03-18VYGR3.770.061.757119
2026-03-19VYGR3.730.061.407157
2026-03-20VYGR3.850.070.077153
2026-03-23VYGR3.880.048.836267
2026-03-24VYGR3.920.050.006297
2026-03-25VYGR4.030.050.166303
2026-03-26VYGR4.140.050.006369
2026-03-27VYGR3.970.057.766713
2026-03-30VYGR3.880.080.006939
2026-03-31VYGR3.870.080.006939
2026-04-01VYGR3.980.080.006941
2026-04-02VYGR3.950.080.006939
2026-04-06VYGR3.970.080.006936
2026-04-07VYGR3.960.080.007047
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1



20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09VYGR4.1112.9- -2.09
2026-03-10VYGR4.9912.9- -2.09
2026-03-11VYGR4.8412.9- -2.09
2026-03-12VYGR4.8712.9- -2.09
2026-03-13VYGR4.45-4.7- -1.76
2026-03-17VYGR3.93-5.4- -1.85
2026-03-18VYGR3.77-5.4- -1.85
2026-03-19VYGR3.73-5.4- -1.85
2026-03-20VYGR3.852.7- -1.77
2026-03-23VYGR3.882.7- -1.77
2026-03-24VYGR3.922.7- -1.77
2026-03-25VYGR4.042.7- -1.77
2026-03-26VYGR4.142.7- -1.77
2026-03-27VYGR3.972.7- -1.77
2026-03-30VYGR3.862.7- -1.77
2026-03-31VYGR3.862.7- -1.77
2026-04-01VYGR3.982.7- -1.77
2026-04-02VYGR3.952.7- -1.77
2026-04-06VYGR3.972.7- -1.77
2026-04-07VYGR3.972.7- -1.77
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1



20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09VYGR-0.761.707.35
2026-03-10VYGR-0.761.707.35
2026-03-11VYGR-0.761.707.00
2026-03-12VYGR-0.711.706.53
2026-03-13VYGR-0.711.706.53
2026-03-17VYGR-0.711.426.53
2026-03-18VYGR-0.711.426.53
2026-03-19VYGR-0.711.426.53
2026-03-20VYGR-0.711.426.53
2026-03-23VYGR-0.711.426.53
2026-03-24VYGR-0.711.426.53
2026-03-25VYGR-0.711.426.50
2026-03-26VYGR-0.711.426.50
2026-03-27VYGR-0.711.426.50
2026-03-30VYGR-0.711.426.50
2026-03-31VYGR-0.711.426.50
2026-04-01VYGR-0.711.426.50
2026-04-02VYGR-0.711.426.50
2026-04-06VYGR-0.811.426.50
2026-04-07VYGR-0.811.426.50
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS​

-0.46

Avg. EPS Est. Current Quarter

-0.52

Avg. EPS Est. Next Quarter

-0.48

Insider Transactions

-0.81

Institutional Transactions

1.42

Beta

1.4

Average Sales Estimate Current Quarter

8

Average Sales Estimate Next Quarter

9

Fair Value

Quality Score

18

Growth Score

30

Sentiment Score

40

Actual DrawDown %

72.3

Max Drawdown 5-Year %

-80.5

Target Price

14.89

P/E

Forward P/E

PEG

P/S

5.85

P/B

1.19

P/Free Cash Flow

EPS

-2.04

Average EPS Est. Cur. Y​

-1.77

EPS Next Y. (Est.)

-1.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-296.53

Relative Volume

0.79

Return on Equity vs Sector %

-88.5

Return on Equity vs Industry %

-72

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.21

EBIT Estimation

◆ VYGR Healthcare
$3.96
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
8/20
Pullback
20/25
Volume
9/15
Valuation
12/20
TP/AR
2/10
Options
7/10
RSI
48.7
Range 1M
15.9%
Sup Dist
2.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
32 /100
WEAK
Momentum
4/25
Growth
16/30
Estimates
0/20
Inst/Vol
4/15
Options
8/10
EPS Yr
11.2%
EPS NY
5%
52W%
44.6%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +276% upside
Quality
6/30
Valuation
16/30
Growth
13/25
Stability
7/10
LT Trend
3/5
Upside
+276%
Quality
18
Click a card to see score breakdown Full Analysis →
Voyager Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 141
Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
VYGR

Latest News

—
Caricamento notizie per VYGR…
stock quote shares  VYGR – Voyager Therapeutics, Inc. Stock Price stock today
news today  VYGR – Voyager Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch  VYGR – Voyager Therapeutics, Inc. yahoo finance google finance
stock history  VYGR – Voyager Therapeutics, Inc. invest stock market
stock prices VYGR premarket after hours
ticker VYGR fair value insiders trading